Table 2.
Cohort characteristics at the end of follow-up
| All | LSD | MSD | HSD | P value | |
|---|---|---|---|---|---|
| Duration of F/U years, mean (SD) | 1.5 (0.91) | 1.5 (0.88) | 1.6 (0.91) | 1.47 (0.93) | 0.54 |
| α24-h USE mEq/day, mean (SD) | 156 (86) | 79 (23) | 124 (31) | 222 (87) | <0.01 |
| Change in eGFR/year, ml/min/1.73 m2; mean (SD) | 2.7 (5.0) | 2.51 (5.2) | 3.36 (5.5) | 3.33 (6.4) | 0.55 |
| ESRD n (%) | 105 (30.8) | 22 (26.8) | 35 (30.2) | 48 (33.6) | 0.74 |
| Deaths n (%) | 10 (2.9) | 3 (3.7) | 3 (2.6) | 4 (2.8) | 0.91 |
SD standard deviation, F/U follow-up, USE urinary sodium excretion, eGFR estimated glomerular filtration rate, ESRD end stage renal disease
αCorrected for creatinine excretion